Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Thermic Sciences International (ENDO)
Colorado Springs, CO, US
Thermic Sciences International develops and sells hemp based products. The company offers hemp formulation-based health and wellness solutions, as well as cosmeceuticals, nutraceuticals, and food brands. It also provides over the counter products for hair and skin include Hempery miracle oil, a skin care solution; Hemp milk body wash, a creamy soap; Hemp lotion bars for moisturizing hands and body; Hemp rose soap; and Hemtastique lip and body balms. The company also develops products for ailments, such as acquired immune deficiency syndrome/human immunodeficiency virus, asthma, cancer, glaucoma, influenza, pain management, and post-traumatic stress disorder. It distributes its products in the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan through online and in retail stores. The company was incorporated in 1969 and is based in Colorado Springs, Colorado.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -50.00% | -99.67% | -98.91% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Communication Equipment: +9.8%—
-
EPS growth Communication Equipment: +36.4%+9.1% Q1'13: -75.2% (vs Q1'12)
-
FCF margin FCF growth · Communication Equipment: +59.0%—
-
EBIT margin Communication Equipment: +4.7%—
-
ROIC Communication Equipment: +3.7%— Q1'13: +266.7% (vs Q1'12)
-
Share dilution Communication Equipment: +0.0%+86.5% Q1'13: +48.6% (vs Q1'12)
-
Debt / EBITDA Net debt/EBITDA · Communication Equipment: -1.04×-0.20× Q1'13: -0.08× (vs Q1'12)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Thomas Bridge and Opportunity Fund, L.P. | 11.34M | 36.00% | 11.34M | — | 11.34M | 10.00 | PN | America. | 2008-07-22 | ↗ |
| 2 | John Thomas Bridge and Opportunity Fund, L.P. | 1.88M | 5.90% | 1.88M | — | 1.88M | 10.00 | PN | the laws of the State of Delaware, the United States of America. | 2007-12-14 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2008-01-30 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 2,696 | 6.95 | 18.7K | 1,721,915 | — | ↗ |
| 2008-01-29 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 2,500 | 6.95 | 17.4K | 1,718,831 | — | ↗ |
| 2008-01-28 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 100 | 6.35 | 635.00 | 1,716,231 | — | ↗ |
| 2008-01-25 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 800 | 6.65 | 5.3K | 1,716,131 | — | ↗ |
| 2008-01-24 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 200 | 6.65 | 1.3K | 1,714,628 | — | ↗ |
| 2007-12-12 | Frazier Healthcare V, LP | 10% Owner | P-Purchase | A | Common Stock | 116,667 | 7.75 | 904.2K | 1,697,563 | — | ↗ |
| 2007-12-07 | Frazier Healthcare V, LP | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 1,580,896 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alfredo Dupetit-Bernardi | Vice President of European Operations & Director | — | male |
| Anthony Spring | Head of Technology Development & Director | — | male |
| C. K. Tam | Treasurer, Secretary & Director | — | male |
| Graciela Moreno | Senior Vice President & Director | — | female |
| Raymond C. Dabney | President & Chief Executive Officer | — | male |
| Robert James Kane | Chief Financial Officer & Director | — | male |
| Wayne Howey | Head of Food Services | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ENDO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
